Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$161.55
-2.79%
Mkt Cap $23.91B
Analyst Ratings
Buy
7
Hold
7
Sell
3
Price Target (64 analysts)
$147.13
Range $110.00 – $170.00
Implied Upside
-8.9%
Consensus $147.13 vs current $161.55